At a glance
- Originator Merck Serono
- Class Small molecules
- Mechanism of Action Mitogen-activated protein kinase 10 inhibitors; Mitogen-activated protein kinase 9 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation; Ischaemia